ON-DEMAND WEBINAR: Next-Generation Sequencing Applications for Antiviral Drug Development
November 11, 2022
This presentation covers the importance of detecting and controlling novel variants in antiviral therapy and vaccine development. It reviews NGS procedures and data submissions for assessing resistance in antiviral drug development, and discusses FDA guidelines for submitting NGS data to the Division of Antiviral Products.
